STERIS plc (STE) stock

STENYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends March 31

Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 21/3011% below fair value

$227.12−5.02 (-2.16%)

Close on Oct 30, 2026Market cap $22.14BP/E 27.8Yield 1.08%

Earnings

Steris's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Nov 4, 2026

Q2 FY2027 · estimated, after the close

Revenue, Q1 FY2027

$1.50B

+7.1% on a year earlier

adjusted EPS per diluted share, Q1 FY2027

$2.59

$2.34 a year earlier

Latest guidance

Raised

Aug 5, 2026 · 7 items

Quarterly results

Revenue and earnings per share from each of Steris's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q2 FY2027ended Sep 30, 2026	Nov 4, 2026Expected	–	–	–	–	–
Q1 FY2027ended Jun 30, 2026	Aug 5, 2026after the close	$1.50B	+7.1%	$2.04	$2.59	Release
Q4 FY2026ended Mar 31, 2026	May 11, 2026after the close	$1.60B	+6.7%	$2.24	$2.83	Release
Q3 FY2026ended Dec 31, 2025	Feb 4, 2026after the close	$1.50B	+7.1%	$1.96	$2.53	Release
Q2 FY2026ended Sep 30, 2025	Nov 5, 2025after the close	$1.50B	+15.4%	$1.94	$2.47	Release
Q1 FY2026ended Jun 30, 2025	Aug 6, 2025after the close	$1.40B	+7.7%	$1.79	$2.34	Release
Q4 FY2025ended Mar 31, 2025	May 14, 2025after the close	$1.50B	0.0%	$1.48	$2.74	Release
Q3 FY2025ended Dec 31, 2024	Feb 5, 2025after the close	$1.40B	0.0%	$1.75	$2.32	Release
Q2 FY2025ended Sep 30, 2024	Nov 6, 2024after the close	$1.30B	-3.0%	$1.51	$2.14	Release
Q1 FY2025ended Jun 30, 2024	Aug 6, 2024after the close	$1.30B	+1.6%	$1.41	$2.03	Release
Q4 FY2024ended Mar 31, 2024	May 8, 2024after the close	$1.50B	+8.7%	-$0.01	$2.58	Release
Q3 FY2024ended Dec 31, 2023	Feb 7, 2024after the close	$1.40B	+14.8%	$1.42	$2.22	Release
Q2 FY2024ended Sep 30, 2023	Nov 7, 2023after the close	$1.34B	+11.7%	$1.16	$2.03	Release
Q1 FY2024ended Jun 30, 2023	Aug 1, 2023after the close	$1.28B	+6.7%	$1.25	$2.00	Release
Q4 FY2023ended Mar 31, 2023	May 10, 2023after the close	$1.38B	+15.0%	$1.88	$2.30	Release
Q3 FY2023ended Dec 31, 2022	Feb 8, 2023after the close	$1.22B	+1.7%	$1.24	$2.02	Release
Q2 FY2023ended Sep 30, 2022	Nov 9, 2022after the close	$1.20B	+0.3%	-$3.15	$1.99	Release
Q1 FY2023ended Jun 30, 2022	Aug 2, 2022after the close	$1.20B	–	$1.10	$1.90	Release
Q4 FY2022ended Mar 31, 2022	May 12, 2022after the close	$1.20B	–	$0.52	$2.04	Release
Q3 FY2022ended Dec 31, 2021	Feb 8, 2022after the close	$1.20B	–	$1.42	$2.12	Release
Q2 FY2022ended Sep 30, 2021	Nov 2, 2021after the close	$1.20B	–	$0.69	$1.99	Release
Q1 FY2022ended Jun 30, 2021	Aug 9, 2021after the close	–	–	–	–	Release
Q4 FY2021ended Mar 31, 2021	May 18, 2021after the close	–	–	–	–	Release
Q3 FY2021ended Dec 31, 2020	Feb 2, 2021after the close	–	–	–	–	Release
Q2 FY2021ended Sep 30, 2020	Nov 2, 2020after the close	–	–	–	–	Release
Q1 FY2021ended Jun 30, 2020	Aug 3, 2020after the close	–	–	–	–	Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Steris's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
as reported revenue growthGAAP	FY2027	+7% – +8%	+7% – +8%	Reaffirmed	Aug 5, 2026
constant currency organic revenue growthnon-GAAP	FY2027	+6% – +7%	+6% – +7%	Reaffirmed	Aug 5, 2026
Net income from continuing operations per diluted shareGAAP	FY2027	$8.92 – $9.12	$9.00 – $9.20	Lowered	Aug 5, 2026
Adjusted earnings per diluted sharenon-GAAP	FY2027	$11.10 – $11.30	$11.10 – $11.30	Reaffirmed	Aug 5, 2026
Free cash flownon-GAAP	FY2027	$800.00M	$850.00M	Lowered	Aug 5, 2026
capital expenditures	FY2027	$450.00M	$375.00M	Raised	Aug 5, 2026
Cash flows from operating activitiesGAAP	FY2027	$1.25B	–	New	Aug 5, 2026
effective tax rate	FY2027	25%	–	New	May 11, 2026

Guidance vs results

The last range Steris gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
FY2026	Adjusted earnings per diluted share from continuing operations	$10.15 – $10.30	$10.17Σ4Q	Within range
FY2026	EPS (GAAP)	$7.97 – $8.12	$7.93Σ4Q	Below range
FY2026	Revenue growth	+8% – +9%	+9.09%Σ4Q	Above range
FY2025	Adjusted earnings per diluted share from continuing operations	$9.05 – $9.15	$9.23Σ4Q	Above range
FY2025	EPS (GAAP)	$6.66 – $6.76	$6.15Σ4Q	Below range
FY2025	Revenue growth	+6%	-0.36%Σ4Q	Below range

Guidance history

Every forecast Steris put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Aug 5, 2026	capital expenditures	FY2027	$450.00M	Raised
Aug 5, 2026	Adjusted earnings per diluted share	FY2027	$11.10 – $11.30	Reaffirmed
Aug 5, 2026	Net income from continuing operations per diluted share	FY2027	$8.92 – $9.12	Lowered
Aug 5, 2026	Free cash flow	FY2027	$800.00M	Lowered
Aug 5, 2026	Cash flows from operating activities	FY2027	$1.25B	New
Aug 5, 2026	as reported revenue growth	FY2027	+7% – +8%	Reaffirmed
Aug 5, 2026	constant currency organic revenue growth	FY2027	+6% – +7%	Reaffirmed
May 11, 2026	Capital expenditures	FY2027	$375.00M	New
May 11, 2026	Adjusted earnings per diluted share	FY2027	$11.10 – $11.30	New
May 11, 2026	Net income from continuing operations per diluted share	FY2027	$9.00 – $9.20	New
May 11, 2026	free cash flow	FY2027	$850.00M	New
May 11, 2026	effective tax rate	FY2027	25%	New
May 11, 2026	as reported revenue	FY2027	+7% – +8%	New
May 11, 2026	constant currency organic revenue growth	FY2027	+6% – +7%	New
Feb 4, 2026	Capital expenditures	FY2026	$375.00M	Reaffirmed
Feb 4, 2026	Adjusted earnings per diluted share from continuing operations	FY2026	$10.15 – $10.30	Reaffirmed
Feb 4, 2026	Net income from continuing operations per diluted share	FY2026	$7.97 – $8.12	Lowered
Feb 4, 2026	free cash flow	FY2026	$850.00M	Reaffirmed
Feb 4, 2026	as reported revenue from continuing operations	FY2026	+8% – +9%	Reaffirmed
Feb 4, 2026	constant currency organic revenue from continuing operations growth	FY2026	+7% – +8%	Reaffirmed
Nov 5, 2025	Capital expenditures	FY2026	$375.00M	Reaffirmed
Nov 5, 2025	Adjusted earnings per diluted share from continuing operations	FY2026	$10.15 – $10.30	Raised
Nov 5, 2025	Net income from continuing operations per diluted share	FY2026	$8.04 – $8.19	Raised
Nov 5, 2025	Free cash flow	FY2026	$850.00M	Raised
Nov 5, 2025	effective tax rate	FY2026	24%	New
Nov 5, 2025	Cash flows from operating activities	FY2026	$1.23B	Raised
Nov 5, 2025	as reported revenue from continuing operations	FY2026	+8% – +9%	Reaffirmed
Nov 5, 2025	Constant currency organic revenue from continuing operations	FY2026	+7% – +8%	Raised
Aug 6, 2025	Capital expenditures	FY2026	$375.00M	Reaffirmed
Aug 6, 2025	Adjusted earnings per diluted share from continuing operations	FY2026	$9.90 – $10.15	Reaffirmed
Aug 6, 2025	Net income from continuing operations per diluted share	FY2026	$7.79 – $8.04	Lowered
Aug 6, 2025	Free cash flow	FY2026	$820.00M	Raised
Aug 6, 2025	Cash flows from operating activities	FY2026	$1.20B	New
Aug 6, 2025	as reported revenue from continuing operations	FY2026	+8% – +9%	Raised
Aug 6, 2025	constant currency organic revenue growth from continuing operations	FY2026	+6% – +7%	Reaffirmed
May 14, 2025	Capital expenditures	FY2026	$375.00M	New
May 14, 2025	Adjusted earnings per diluted share from continuing operations	FY2026	$9.90 – $10.15	New
May 14, 2025	Net income from continuing operations per diluted share	FY2026	$7.82 – $8.07	New
May 14, 2025	free cash flow	FY2026	$770.00M	New
May 14, 2025	as reported revenue from continuing operations	FY2026	+6% – +7%	New
May 14, 2025	constant currency organic revenue growth from continuing operations	FY2026	+6% – +7%	New
Feb 5, 2025	Capital expenditures	FY2025	$360.00M	Reaffirmed
Feb 5, 2025	Adjusted earnings per diluted share from continuing operations	FY2025	$9.05 – $9.15	Lowered
Feb 5, 2025	Net income from continuing operations per diluted share	FY2025	$6.66 – $6.76	Lowered
Feb 5, 2025	free cash flow	FY2025	$700.00M	Reaffirmed
Feb 5, 2025	effective tax rate	FY2025	23%	Reaffirmed
Feb 5, 2025	as reported revenue	FY2025	+6%	Lowered
Feb 5, 2025	Constant currency organic revenue from continuing operations	FY2025	+6%	Lowered
Nov 6, 2024	Capital expenditures	FY2025	$360.00M	New
Nov 6, 2024	Adjusted earnings per diluted share from continuing operations	FY2025	$9.05 – $9.25	New
Nov 6, 2024	Net income from continuing operations per diluted share	FY2025	$6.70 – $6.90	New
Nov 6, 2024	free cash flow	FY2025	$700.00M	New
Nov 6, 2024	effective tax rate	FY2025	23%	New
Nov 6, 2024	Cash flows from operating activities	FY2025	$1.06B	New
Nov 6, 2024	Constant currency organic revenue from continuing operations	FY2025	+6% – +7%	New
Nov 6, 2024	as reported revenue	FY2025	+6.5% – +7.5%	New
Aug 6, 2024	Capital expenditures	FY2025	$360.00M	Reaffirmed
Aug 6, 2024	Adjusted earnings per diluted share from continuing operations	FY2025	$9.05 – $9.25	Reaffirmed
Aug 6, 2024	Net income from continuing operations per diluted share	FY2025	$6.70 – $6.90	Raised
Aug 6, 2024	free cash flow	FY2025	$700.00M	Reaffirmed
Aug 6, 2024	effective tax rate	FY2025	23%	Reaffirmed
Aug 6, 2024	as reported revenue from continuing operations	FY2025	+6.5% – +7.5%	Reaffirmed
Aug 6, 2024	Constant currency organic revenue from continuing operations	FY2025	+6% – +7%	Reaffirmed
May 8, 2024	Capital expenditures	FY2025	$360.00M	New
May 8, 2024	Adjusted earnings per diluted share from continuing operations	FY2025	$9.05 – $9.25	New
May 8, 2024	Net income from continuing operations per diluted share	FY2025	$6.55 – $6.75	New
May 8, 2024	free cash flow	FY2025	$700.00M	New
May 8, 2024	effective tax rate	FY2025	23%	New
May 8, 2024	as reported revenue from continuing operations	FY2025	+6.5% – +7.5%	New
May 8, 2024	Constant currency organic revenue from continuing operations	FY2025	+6% – +7%	New
Feb 7, 2024	Purchases of property, plant, equipment, and intangibles, net	FY2024	$310.00M	New
Feb 7, 2024	Adjusted earnings per diluted share	FY2024	$8.60 – $8.70	Lowered
Feb 7, 2024	Net income per diluted share	FY2024	$5.35 – $5.45	Lowered
Feb 7, 2024	Free Cash Flow	FY2024	$685.00M	Reaffirmed
Feb 7, 2024	Cash flows from operating activities	FY2024	$995.00M	Lowered
Feb 7, 2024	as reported revenue	FY2024	+10% – +11%	Raised
Feb 7, 2024	constant currency organic revenue growth	FY2024	+7% – +8%	Raised
Nov 7, 2023	Adjusted earnings per diluted share	FY2024	$8.60 – $8.80	Reaffirmed
Nov 7, 2023	Free cash flow	FY2024	$685.00M	Reaffirmed
Nov 7, 2023	as reported revenue growth	FY2024	+9% – +10%	Reaffirmed
Nov 7, 2023	constant currency organic revenue growth	FY2024	+6% – +7%	Reaffirmed
Aug 1, 2023	Adjusted earnings per diluted share	FY2024	$8.60 – $8.80	Raised
Aug 1, 2023	Free cash flow	FY2024	$685.00M	Lowered
Aug 1, 2023	as reported revenue	FY2024	+9% – +10%	Raised
Aug 1, 2023	constant currency organic revenue growth	FY2024	+6% – +7%	Reaffirmed
May 10, 2023	Capital expenditures	FY2024	$375.00M	New
May 10, 2023	Adjusted earnings per diluted share	FY2024	$8.55 – $8.75	New
May 10, 2023	Net income per diluted share	FY2024	$5.67 – $5.87	New
May 10, 2023	free cash flow	FY2024	$700.00M	New
May 10, 2023	effective tax rate	FY2024	23%	New
May 10, 2023	Cash flows from operating activities	FY2024	$1.08B	New
May 10, 2023	as reported revenue	FY2024	+7% – +8%	New
May 10, 2023	Constant currency organic revenue growth	FY2024	+6% – +7%	New
Feb 8, 2023	adjusted earnings per diluted share	FY2023	$8.00 – $8.10	Lowered
Feb 8, 2023	Net income per diluted share	FY2023	$0.56 – $0.66	Lowered
Feb 8, 2023	free cash flow	FY2023	$500.00M	Lowered
Feb 8, 2023	As reported revenue	FY2023	+6%	Lowered
Feb 8, 2023	Constant currency organic revenue	FY2023	+7%	Lowered
Nov 9, 2022	adjusted earnings per diluted share	FY2023	$8.40 – $8.60	Reaffirmed
Nov 9, 2022	Net income per diluted share	FY2023	$1.07 – $1.27	New
Nov 9, 2022	free cash flow	FY2023	$600.00M	Lowered
Nov 9, 2022	as reported revenue	FY2023	+8%	Lowered
Nov 9, 2022	Constant currency organic revenue	FY2023	+10%	Reaffirmed
Aug 2, 2022	Adjusted earnings per diluted share	FY2023	$8.40 – $8.60	Lowered
Aug 2, 2022	As reported revenue	FY2023	+9%	Lowered
Aug 2, 2022	constant currency organic revenue growth	FY2023	+10%	Lowered
May 11, 2022	Capital expenditures	FY2023	$330.00M	New
May 11, 2022	Adjusted earnings per diluted share	FY2023	$8.55 – $8.75	New
May 11, 2022	free cash flow	FY2023	$675.00M	New
May 11, 2022	As reported revenue	FY2023	+12%	New
May 11, 2022	constant currency organic revenue growth	FY2023	+11%	New
Feb 8, 2022	Capital expenditures	FY2022	$300.00M	New
Feb 8, 2022	Adjusted earnings per diluted share	FY2022	$7.85 – $7.95	Raised
Feb 8, 2022	Net income per diluted share	FY2022	$3.12 – $3.22	New
Feb 8, 2022	free cash flow	FY2022	$420.00M	New
Feb 8, 2022	Constant currency organic revenue growth	FY2022	+11%	Raised
Nov 2, 2021	adjusted earnings per share	FY2022	$7.60 – $7.85	New
Nov 2, 2021	constant currency organic revenue growth	FY2022	+10% – +11%	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.